UTHR in the 13F filings
United Therapeutics Corp Del · CUSIP 91307C102
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 23 Jan 2026
- Managers listing it
- 32
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 14 listed it in both
- Shares listed
- 9,885,131
- combined, among listed positions
- Reported value
- $4.8bn
- combined, at the quarter end
Among the 92 comparable managers: 17 buyers (opened or added shares) and 20 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +1,642,585.
Managers listing UTHR in Q4 2025
32 of 32 holders
Largest increases and reductions, by shares
Increases
- Wellington Management Group LLPexisting position · 2,441,492 shares now+1,042,711
- Janus Henderson Group Ltdexisting position · 796,101 shares now+341,383
- Baillie Gifford & Conew position · 323,016 shares now+323,016
- AQR Capital Management LLCexisting position · 1,281,699 shares now+295,221
- D. E. Shaw & Co.existing position · 306,971 shares now+242,260
Reductions
- Renaissance Technologies LLCexisting position · 1,909,259 shares now-264,133
- Millennium Management LLCexisting position · 64,073 shares now-194,504
- Susquehanna International Group LLPexisting position · 13,692 shares now-162,839
- Arrowstreet Capital LPexisting position · 69,367 shares now-139,168
- Balyasny Asset Management LLCexisting position · 55,934 shares now-90,964
New positions and exits
New (3)
Exited (5)
- Squarepoint Ops LLCwas $13m
- Hudson Bay Capital Management LPwas $9.0m
- Winton Group Ltdwas $8.8m
- Voloridge Investment Management LLCwas $6.6m
- Two Sigma Advisers LPwas $671k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 5 | $378m | n.a. | n.a. |
| Q3 2013 | 5 | $587m | n.a. | n.a. |
| Q4 2013 | 9 | $1.1bn | n.a. | n.a. |
| Q1 2014 | 8 | $923m | n.a. | n.a. |
| Q2 2014 | 9 | $716m | n.a. | n.a. |
| Q3 2014 | 11 | $1.1bn | n.a. | n.a. |
| Q4 2014 | 10 | $1.2bn | n.a. | n.a. |
| Q1 2015 | 14 | $1.6bn | n.a. | n.a. |
| Q2 2015 | 14 | $1.6bn | n.a. | n.a. |
| Q3 2015 | 16 | $1.3bn | n.a. | n.a. |
| Q4 2015 | 16 | $1.6bn | n.a. | n.a. |
| Q1 2016 | 17 | $1.1bn | n.a. | n.a. |
| Q2 2016 | 12 | $869m | n.a. | n.a. |
| Q3 2016 | 14 | $1.0bn | n.a. | n.a. |
| Q4 2016 | 10 | $1.1bn | n.a. | n.a. |
| Q1 2017 | 13 | $1.1bn | n.a. | n.a. |
| Q2 2017 | 12 | $1.2bn | n.a. | n.a. |
| Q3 2017 | 8 | $1.1bn | n.a. | n.a. |
| Q4 2017 | 10 | $1.4bn | n.a. | n.a. |
| Q1 2018 | 8 | $1.0bn | n.a. | n.a. |
| Q2 2018 | 10 | $996m | n.a. | n.a. |
| Q3 2018 | 9 | $1.1bn | n.a. | n.a. |
| Q4 2018 | 9 | $1.0bn | n.a. | n.a. |
| Q1 2019 | 9 | $1.1bn | n.a. | n.a. |
| Q2 2019 | 15 | $804m | n.a. | n.a. |
| Q3 2019 | 17 | $913m | n.a. | n.a. |
| Q4 2019 | 14 | $863m | n.a. | n.a. |
| Q1 2020 | 14 | $1.2bn | n.a. | n.a. |
| Q2 2020 | 14 | $1.4bn | n.a. | n.a. |
| Q3 2020 | 10 | $797m | n.a. | n.a. |
| Q4 2020 | 11 | $1.2bn | n.a. | n.a. |
| Q1 2021 | 10 | $1.4bn | n.a. | n.a. |
| Q2 2021 | 11 | $1.5bn | n.a. | n.a. |
| Q3 2021 | 16 | $1.5bn | n.a. | n.a. |
| Q4 2021 | 14 | $1.9bn | n.a. | n.a. |
| Q1 2022 | 14 | $1.7bn | n.a. | n.a. |
| Q2 2022 | 18 | $2.3bn | n.a. | n.a. |
| Q3 2022 | 17 | $2.2bn | n.a. | n.a. |
| Q4 2022 | 18 | $2.9bn | n.a. | n.a. |
| Q1 2023 | 16 | $2.5bn | n.a. | n.a. |
| Q2 2023 | 12 | $2.5bn | n.a. | n.a. |
| Q3 2023 | 13 | $2.4bn | n.a. | n.a. |
| Q4 2023 | 14 | $2.3bn | 8 | 6 |
| Q1 2024 | 19 | $2.2bn | 14 | 6 |
| Q2 2024 | 14 | $2.5bn | 8 | 7 |
| Q3 2024 | 10 | $2.9bn | 6 | 4 |
| Q4 2024 | 14 | $3.3bn | 8 | 4 |
| Q1 2025 | 14 | $2.1bn | 7 | 6 |
| Q2 2025 | 14 | $1.9bn | 9 | 5 |
| Q3 2025 | 16 | $2.6bn | 8 | 10 |
| Q4 2025 | 14 | $3.8bn | 17 | 20 |
| Q1 2026 | 18 | $5.1bn | 18 | 17 |
| Q2 2026 | 14 | $3.5bn | 19 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
UTHR and LLY →UTHR and JNJ →UTHR and VRTX →Choose a stock to compare with UTHR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own UTHR, latest filings →Back to the 13F Explorer →